Literature DB >> 9002874

Shared antigens of Porphyromonas gingivalis and Bacteroides forsythus.

D Vasel1, T J Sims, B Bainbridge, L Houston, R Darveau, R C Page.   

Abstract

Periodontitis in humans is caused by a group of predominantly gram-negative, anaerobic bacteria among which Porphyromonas gingivalis and Bacteroides forsythus are prominent. A similar group is present and presumably plays a similar role in experimental periodontitis in the primate Macaca fascicularis. Nevertheless, immunization using a vaccine containing only killed P. gingivalis suppresses the progress of experimental periodontitis in M. fascicularis. We investigated the hypothesis that gram-negative periodontopathic bacterial may share antigens, and immunization with one species may induce antibodies reactive with other gram-negative species. Using enzyme-linked immunosorbent assay (ELISA), Western and dot immunoblots with nonabsorbed and absorbed and immune and preimmune sera we show that monkeys immunized with P. gingivalis produce antibodies reactive not only with antigens of P. gingivalis but also with those of B. forsythus. Similarly, rabbits immunized with P. gingivalis or with B. forsythus produce antibodies that react with antigens of both bacteria. Cross-reactive antibodies bind to epitopes in lipid A and possibly in core carbohydrate of lipopolysaccharide. Using complexes of lipopolysaccharide with polymyxin B, bovine serum albumin and apolipoprotein A1 specificity of binding was documented. Using sera from monkeys immunized with P. gingivalis, cross-reactivity with Actinobacillus actinomycetemcomitans could not be demonstrated by ELI-SA, although binding to lipopolysaccharide but not to lipid A was demonstrated by Western and dot immunoblots. Antibodies to shared lipopolysaccharide epitopes of periodontopathic bacteria may account, at least in part, for the immune protection observed in immunized monkeys, and shared epitopes may have potential as a vaccine for periodontitis in humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9002874     DOI: 10.1111/j.1399-302x.1996.tb00174.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  5 in total

1.  Expression and immunogenicity of hemagglutinin A from Porphyromonas gingivalis in an avirulent Salmonella enterica serovar typhimurium vaccine strain.

Authors:  E Kozarov; N Miyashita; J Burks; K Cerveny; T A Brown; W P McArthur; A Progulske-Fox
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  Serum antibodies to Porphyromonas gingivalis block the prostaglandin E2 response to lipopolysaccharide by mononuclear cells.

Authors:  B W Bainbridge; R C Page; R P Darveau
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

3.  Antigenic variation and cross-reactivity in Bacteroides forsythus clinical isolates detected by western blot.

Authors:  T J Sims; L A Mancl; P H Braham; B W Bainbridge; R C Page
Journal:  J Clin Immunol       Date:  1998-09       Impact factor: 8.317

4.  Immunoglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients.

Authors:  Ketil Moen; Johan G Brun; Tor Magne Madland; Turid Tynning; Roland Jonsson
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

5.  Vaccines against periodontitis: a forward-looking review.

Authors:  Jeom-Il Choi; Gregory J Seymour
Journal:  J Periodontal Implant Sci       Date:  2010-08-30       Impact factor: 2.614

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.